Vis enkel innførsel

dc.contributor.authorRaudeberg, Rune
dc.contributor.authorIverson, Grant L.
dc.contributor.authorHammar, Åsa
dc.date.accessioned2022-05-11T08:18:36Z
dc.date.available2022-05-11T08:18:36Z
dc.date.created2019-06-20T14:24:08Z
dc.date.issued2019
dc.identifier.issn1385-4046
dc.identifier.urihttps://hdl.handle.net/11250/2995195
dc.description.abstractObjective: To illustrate and quantify how using different normative systems influences the accuracy of identifying cognitive impairment in people with schizophrenia spectrum disorders. Participants and methods: A convenience sample of 315 patients between 18 and 38 years of age referred for neuropsychological assessment at a psychiatric inpatient hospital in Bergen, Norway, was included. All completed the Norwegian version of the Repeatable Battery for the Assessment of Neuropsy-chological Status (RBANS). Results: There were statistically significant differences between the Immediate Memory, Visuospatial/Constructional, Language, Delayed Memory, and Total Scale Index scores when comparing the U.S. normative scores with the Scandinavian normative scores. The effect sizes were medium. The patient samples scored higher when using the U.S. normative data, suggesting less cognitive impairment. Conclusions: United States normative data yielded less impaired scores for Norwegians with schizophrenia spectrum disorders. The implications of using U.S. versus Scandinavian normative data are discussed.en_US
dc.language.isoengen_US
dc.publisherTaylor & Francisen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/deed.no*
dc.titleNorms matter: U.S. normative data under-estimate cognitive deficits in Norwegians with schizophrenia spectrum disordersen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionacceptedVersionen_US
dc.rights.holderCopyright 2019 Informa UK Limiteden_US
cristin.ispublishedtrue
cristin.fulltextpostprint
cristin.fulltextpostprint
cristin.fulltextpostprint
cristin.fulltextpostprint
cristin.qualitycode1
dc.identifier.doi10.1080/13854046.2019.1590641
dc.identifier.cristin1706495
dc.source.journalThe Clinical Neuropsychologisten_US
dc.source.pagenumber58-74en_US
dc.identifier.citationThe Clinical Neuropsychologist. 2019, 33 (sup1), 58-74.en_US
dc.source.volume33en_US
dc.source.issuesup1en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal